Table 1.
Comparison of baseline clinical data between Group A and Group C
| Group A (n = 40) | Group C (n = 40) | t/χ2 value | P value | |
| Gender (Male) | 29 | 31 | 0.267 | 0.606 |
| Age (yr) | 62.82 ± 12.93 | 61.38 ± 10.29 | 0.551 | 0.583 |
| Tumor size (cm) | 3.75 ± 1.21 | 3.68 ± 1.17 | 0.263 | 0.793 |
| Number of tumors | 0.050 | 0.823 | ||
| Single | 22 | 21 | ||
| 2-3 | 18 | 19 | ||
| Child-Pugh classification | 0.054 | 0.816 | ||
| A | 26 | 25 | ||
| B | 14 | 15 | ||
| TBiL (μmol/L) | 18.28 ± 5.28 | 17.83 ± 5.16 | 0.583 | 0.562 |
| AFP (ng/ml) | 612.29 ± 127.38 | 625.93 ± 139.27 | 0.457 | 0.649 |
| ALB (g/L) | 37.19 ± 5.39 | 36.93 ± 5.33 | 0.217 | 0.829 |
| ALT (U/L) | 35.27 ± 15.14 | 36.42 ± 17.46 | 0.315 | 0.754 |
| AST (U/L) | 38.63 ± 15.13 | 40.41 ± 16.52 | 0.503 | 0.617 |
AFP: Alpha-fetoprotein; ALB: Serum albumin; ALT: Aminotransferase; AST: Aspartate aminotransferase; TBiL: Total bilirubin.